Immunohistochemical staining indicated that the carcinoma was positive for estrogen receptor (ER), p53, p120 and E-cadherin, and negative for progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2). The gene discussed is TP53; the disease is carcinoma.